Stocks and Investing
Stocks and Investing
Wed, March 20, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (TNGX) at Strong Buy with Increased Target to $17 on, Mar 20th, 2024
Robert Burns of HC Wainwright & Co., Maintained "Tango Therapeutics, Inc." (TNGX) at Strong Buy with Increased Target from $16 to $17 on, Mar 20th, 2024.
Robert has made no other calls on TNGX in the last 4 months.
There are 2 other peers that have a rating on TNGX. Out of the 2 peers that are also analyzing TNGX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Joseph Catanzaro of "Piper Sandler" Initiated at Buy and Held Target at $18 on, Monday, February 12th, 2024
- Yuan Zhi of "B. Riley Securities" Initiated at Strong Buy and Held Target at $16 on, Friday, December 8th, 2023
Contributing Sources